Clinical Trial Detail

NCT ID NCT04421222
Title Oral EPI-7386 in Patients With Metastatic Castration-Resistant Prostate Cancer (EPI-7386)
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors ESSA Pharmaceuticals
Indications

prostate cancer

Therapies

EPI-7386

Age Groups: adult senior

No variant requirements are available.